Laura Francis

Laura A. Francis is Chief Executive Officer & Director at SI-BONE, Inc. since 2021, Director at Estuary Transit District, and Independent Director at Bruker Corp.
starting in 2025.
Former roles include Director at Stemina Biomarker Discovery, Inc., Independent Director at Shockwave Medical, Inc. from 2019 to 2024, Chief Financial Officer at Bruker Corp.
from 2002 to 2004, Engagement Manager at McKinsey & Co., Inc. from 1995 to 1999, Audit Manager at Coopers & Lybrand LLP from 1988 to 1993, Chief Financial Officer, Treasurer & VP-Finance at Promega Corp.
from 2004 to 2013, Chief Operating & Financial Officer at Nutra-Park, Inc. from 2001 to 2002, Chief Financial Officer at Hypercosm LLC from 1999 to 2001, and Chief Financial Officer at Auxogyn, Inc. from 2012 to 2014.
Education includes undergraduate studies at the University of Wisconsin and an MBA from Stanford University.